Author Archives : Editorial Team

Home  >>  Author : Editorial Team

Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

On March 20, 2018, Posted by , In News, By ,, , With Comments Off on Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

Boehringer Ingelheim and Vanderbilt University announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research partnership will focus on the discovery and development of new chemical therapeutics targeting the pro-survival protein MCL1 as a potential therapy against MCL1 dependent cancers. This is the third…

DKFZ- Diabetes: Are high blood glucose levels an effect rather than the cause of the disease?

On March 19, 2018, Posted by , In Research Article, By , , With Comments Off on DKFZ- Diabetes: Are high blood glucose levels an effect rather than the cause of the disease?

Insulin resistance and elevated blood glucose levels are considered to be the cause of type 2 diabetes. However, scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital have now provided evidence that things might be completely different. They showed in flies that elevated levels of the metabolite…

EMBL: Potential new way to limit antibiotic resistance spreading

On March 19, 2018, Posted by , In Research Article, By , , With Comments Off on EMBL: Potential new way to limit antibiotic resistance spreading

Potential new way to limit antibiotic resistance spreading. IMAGE: Aleksandra Krolik / EMBL EMBL scientists unravel the molecular basis of a major antibiotic resistance transfer mechanism One of the biggest current threats to global health is the rise of multi-drug resistant bacteria, caused by the spreading of antibiotic resistance amongst…

New member: Welcome to PAASP in our cluster

On March 15, 2018, Posted by , In News, By , With Comments Off on New member: Welcome to PAASP in our cluster

We are happy to welcome in our cluster PAASP GmbH (Partnership for Assessment and Accreditation of Scientific Practice). “Quality in Research is the basis for the development of novel drugs.” Anton Bespalov, CEO The PAASP GmbH is a full-service consulting and auditing company that specializes on providing assessment of operational…

EMBL: Chromatin usage reveals developmental trajectories

On March 15, 2018, Posted by , In Research Article, By , , With Comments Off on EMBL: Chromatin usage reveals developmental trajectories

Information (arrows) emanating out of chromatin to give rise to different cell types. IMAGE: Campbell Medical Illustration EMBL scientists show how chromatin usage in individual cells reveals developmental trajectories Both cell type and developmental stage can be deduced from measurements of chromatin accessibility in thousands of single cells, researchers at…

Sciomics: Solving Alzheimers with this company’s new approach?

On March 14, 2018, Posted by , In News, By , , With Comments Off on Sciomics: Solving Alzheimers with this company’s new approach?

Labiotech.eu media recently profiled our member Sciomics, a German Cancer Research Center (DKFZ) spin-off founded in 2013 by a team of researchers led by Dr. Christoph Schröder and Dr. Jörg Hoheisel. Sciomics has developed antibody microarrays as a tool for analyzing complex protein samples. Using their expertise, they are able to address…

University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

On March 13, 2018, Posted by , In News, By , , With Comments Off on University of Heidelberg – Innovation Campus: new construction site for the network “Biology at the nanoscale”

Baden-Württemberg Ministry of Science will support a research bridge between the Ruperto Carola and the Max Planck Institute for Medical Research in Heidelberg, by funding a new building in the life science innovation campus “Heidelberg 4 life”. The funding has been formalized by the Minister of Science, Research and the…

NCT Heidelberg: Combination therapy in neuroblastoma: It`s all about the mix

On March 13, 2018, Posted by , In Research Article, By , , With Comments Off on NCT Heidelberg: Combination therapy in neuroblastoma: It`s all about the mix

The combination of two cell division inhibitors causes malignant nervous system tumors to die off, as scientists from the “Hopp Children’s Cancer Center at the NCT Heidelberg” (KiTZ) have shown in experimental studies.The combination strategy could be the key to new targeted therapies against this aggressive type of tumor. The…

BioMed X and Roche announce research collaboration in the field of immunology

On March 13, 2018, Posted by , In News, By , , With Comments Off on BioMed X and Roche announce research collaboration in the field of immunology

BioMed X announced today the initiation of a new research collaboration with F. Hoffmann-La Roche Ltd in the field of immunology. Within the framework of the agreement, BioMed X will launch a global call for applications to establish a new biomedical research group in Heidelberg. The main objective of the…

Innovation wanted: Baden-Württemberg Innovation Award 2018

On March 12, 2018, Posted by , In Funding/Prize/Competition, By , With Comments Off on Innovation wanted: Baden-Württemberg Innovation Award 2018

Also in 2018, the state of Baden-Württemberg is happy to announce the Innovation Award of the State of Baden-Württemberg (€50.000). The prize is awarded to outstanding small and medium-sized enterprises from industry, trade and technological service located in the Baden-Württemberg active in the development of new products, processes and technological…